🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Total body irradiation (TBI) is a standard part of the conditioning regimen...
Status
Unknown
Location
University Hospital of Geneva
Start Date
2017-04-11
Trial ID
NCT03262220
Treatments Being Tested
This phase I studies the side effects and best dose of total marrow and lym...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2018-07-06
Trial ID
NCT03494569
Treatments Being Tested
This phase I trial is to find out the best dose, possible benefits and/or s...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-07-19
Trial ID
NCT05139004
This is an open-label, single-center, non-randomized phase I/II pilot study...
Status
Recruiting
Location
Institute of Hematology and Blood Transfusion
Start Date
2025-11-21
Trial ID
NCT07532824
Treatments Being Tested
Refractory/relapsed aplastic anemia (AA) in adults remains a clinical chall...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2025-07-20
Trial ID
NCT07078721
Treatments Being Tested
The study is a Phase II clinical trial. Patients will receive intensity-mod...
Status
Recruiting
Location
University of Illinois Cancer Center
Start Date
2025-02-04
Trial ID
NCT06802315
In this phase I trial, patients with relapsed or refractory multiple myelom...
Status
Completed
Location
University of Illinois Cancer Center
Start Date
2014-01-14
Trial ID
NCT02043847
RATIONALE: A peripheral blood stem cell transplant or bone marrow transplan...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-08
Trial ID
NCT00623077
This is a phase I/II clinical trial to determine the maximum tolerated dose...
Status
Withdrawn
Location
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Start Date
2023-10
Trial ID
NCT05201183
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of melphalan a...
Status
Withdrawn
Location
City of Hope Medical Center
Start Date
2018-01
Trial ID
NCT03100877